Image of a person in full PPE holding a shield with a health cross on it up to the coronavirus to show New consortium to monitor safety and effectiveness of COVID-19 vaccines

GSK & Sanofi strike deal to supply UK with up to 60m doses of...

Sanofi and GSK have reached an agreement* with the UK government for the supply of up to 60 million doses of a COVID-19 vaccine. Developed...
Image of coronavirus and a syringe to show Support for developers of COVID-19 medicinal products

High-risk groups should have priority for COVID-19 vaccine – poll

The biopharmaceutical industry believes that high-risk groups should be prioritised for the COVID-19 vaccine, according to a poll by GlobalData. Nearly half of global respondents...
Image of a brain, one sde it the brain, the other side is a puzzle to show Low dose of aspirin no help for dementia

AMBAR clinical trial results published in Journal of the Alzheimer’s Association

Peer-reviewed scientific journal, Alzheimer’s & Dementia: The Journal of the Alzheimer's Association, has published the results of Grifols’ AMBAR clinical trial. This study was...
Graphic image of lungs to show New treatment option for extensive-stage small-cell lung cancer approved

AstraZeneca’s Imfinzi recommended for approval in the EU

AstraZeneca’s Imfinzi (durvalumab) has been recommended for marketing authorisation in the European Union (EU) for the 1st-line treatment of adults with extensive-stage small cell...
Graphic image of coronavirus to show Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19

Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19

Novartis has launched a first-of-its-kind not-for-profit portfolio of medicines for the symptomatic treatment of COVID-19. Novartis has announced a new initiative to help patients in...
Healthcare professioanl with face mask to show Oxford coronavirus vaccine produces strong immune response

Oxford coronavirus vaccine produces strong immune response

A new study has revealed that the Oxford coronavirus vaccine produces a strong immune response. The results of the Phase I/II trial published in the...
Image of a syringe and coronavirus o show UK secures early access to promising COVID-19 vaccine candidates

UK secures early access to promising COVID-19 vaccine candidates

Millions of people could be vaccinated against coronavirus as the UK secures early access to 90 million doses of promising COVID-19 vaccine candidates. Announced by...
IMage of a pen signing on a blue background to show MHRA grants early access to lumasiran

MHRA grants early access to lumasiran

Alnylam has announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted early access to lumasiran. Alnylam Pharmaceuticals, Inc, the leading RNAi therapeutics...
Image of a participant being injected with Medicago COVID-19 vaccine candidate

Medicago begins Phase I clinical trials for its COVID-19 vaccine candidate

Medicago, a biopharmaceutical company headquartered in Quebec City, has started Phase I clinical trials for its plant-derived COVID-19 vaccine candidate, administering the first doses...
Image of two business people shaking hands in front of a contract to show NICE recommends ADCETRIS (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a rare type of lymphoma

NICE recommends ADCETRIS▼ (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a...

Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended ADCETRIS (brentuximab vedotin) with cyclophosphamide, doxorubicin and prednisone...

Latest articles

Logo for Atrial Fibrillation Toolkit: Tackling avoidable strokes to save lives and strain on the NHS

Atrial Fibrillation Toolkit: Tackling avoidable strokes to save lives and strain on the NHS

The AHSN Network of 15 Academic Health Science Networks in England has launched the national ‘Atrial Fibrillation Toolkit’ (www.aftoolkit.co.uk) to address barriers to stroke...
Image of a person presenting data to show Data in NEJM demonstrates efficacy of ofatumumab in patients with relapsing multiple sclerosis

Data in NEJM demonstrates efficacy of ofatumumab in patients with relapsing multiple sclerosis

Novartis announces publication of Phase III ASCLEPIOS trials data in NEJM demonstrating efficacy of the ofatumumab in patients with relapsing multiple sclerosis. Novartis has announced...
Image of business people nurturing plants growing with light bulbs at the top to show Primary care networks and mental health services post COVID-19

Primary care networks and mental health services post COVID-19

Joint working between primary care networks and providers of mental health services must accelerate if the NHS is to help the huge increase in...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a person presenting data to show Data in NEJM demonstrates efficacy of ofatumumab in patients with relapsing multiple sclerosis

Data in NEJM demonstrates efficacy of ofatumumab in patients with relapsing multiple sclerosis

Novartis announces publication of Phase III ASCLEPIOS trials data in NEJM demonstrating efficacy of the ofatumumab in patients with relapsing multiple sclerosis. Novartis has announced...
Woman with mask on phone: use of electronic prescribing

Accelerated use of electronic prescribing

Deborah Evans, Managing Director of Pharmacy Complete, looks at the instruction to stay at home, GP surgeries closing their doors and consumers rethinking how...
Woman holding swab: COVID-19 pandemic

COVID-19: Pharma on the frontline

Pharma stepped up to support the NHS, the country and the World during the COVID-19 pandemic. Pf brings you some examples of pharma on...
Laptop emails: ABPI Code of Practice

ABPI Code and promotional emails

Dr Rina Newton, Managing Director of CompliMed, looks at the considerations relating to the ABPI Code of Practice and promotional emails. In the June issue...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription